As autochthonous lung cancers developed in transgenic mouse models better mimic the clinical course of tumorigenesis and development and faithfully recapitulated the complex interaction between tumor and patients’ immune system, we generated a cohort of TetO-EGFR (Del19)/CC10rtTA bitransgenic mice (designated EGFR-DEL). This evidence concerns the gene EGFR and lung cancer.